[ Price : $8.95]
Former FDA enforcement official suggests new strategies for industry to prepare for agency inspections that rely on artificial int...[ Price : $8.95]
FDA officials are seeking to bolster confidence in generic medicines, highlighting the agency's oversight of drug manufacturing, i...[ Price : $8.95]
FDA launches a new effort to aggregate clinical trial data on kidney safety biomarkers, seeking pharmaceutical industry participat...[ Price : $8.95]
FDA issues an early alert warning healthcare providers about a potentially high-risk defect affecting certain infant resuscitation...[ Price : $8.95]
PhRMA calls on FDA to provide clearer regulatory expectations for the use of digital health technologies in drug development, argu...[ Price : $8.95]
FDA approves an expanded indication for Pfizer's hemophilia treatment Hympavzi (marstacimab-hncq), allowing its use in additional ...[ Price : $8.95]
Stakeholders at FDA's public hearing on the Commissioners National Priority Voucher program urge the agency to temporarily suspend...[ Price : $8.95]
The House passes FDAs appropriations bill for fiscal year 2027 that provides $7.1 billion for the agency.